Enzo Biochem, Inc. (ENZ) Reports Q3 Loss of $0.09/Share
Tweet
Share
E-mailGet Alerts ENZ Hot Sheet
Price: $0.31 --0%
Financial Fact:
Cost of clinical laboratory services: 10.9M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Financial Fact:
Cost of clinical laboratory services: 10.9M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Enzo Biochem, Inc. (NYSE: ENZ) reported Q3 EPS of ($0.09), versus ($0.05) reported last year. Revenue for the quarter came in at $26 million, versus $25.8 million reported last year.
For earnings history and earnings-related data on Enzo Biochem, Inc. (ENZ) click here.
For earnings history and earnings-related data on Enzo Biochem, Inc. (ENZ) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Activist investor presses Xerox to review financial services arm - Bloomberg
- Mission Produce (AVO) Misses Q3 EPS by 2c; offers outlook
- UBS upgrades Lockheed Martin to Buy, sees 26% upside on missile growth
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
